Can I read Impact of quercetin in patients with myocardial infarction. A multicenter, randomized, and open-label pilot study on EtoBox?

Impact of quercetin in patients with myocardial infarction. A multicenter, randomized, and open-label pilot study by Sergey Kozhukhov; Alexander Parkhomenko; Yaroslav Lutay; Nataliia Dovganych is a Medicine article available to read on EtoBox.

What is Impact of quercetin in patients with myocardial infarction. A multicenter, randomized, and open-label pilot study about?

 first anterior STEMI documented according to standard criteria;  hospitalization within 6 hours from the symptoms onset;  indications for reperfusion therapy AMI Reperfusion I/R damage How can we limit infarct size? Pilot randomized clinical trial Cardioprotective drug  Intravenous 5-LO blocker quercetin (before reperfusion and repeatedly during the next 5 days) Novel iv Quercetin formula limits infarct size and prevents intramyocardial hemorrhage in STEMI patients Substudy  evaluation of microvascular obstruction (MVO) and intramyocardial hemorrhage (IMH) by ECGgated Cardiac Magnetic Resonance (CMR)

Who reads Impact of quercetin in patients with myocardial infarction. A multicenter, randomized, and open-label pilot study?

Author

Sergey Kozhukhov; Alexander Parkhomenko; Yaroslav Lutay; Nataliia Dovganych

Publisher

Elsevier BV

Published

2024

Language

EN

Field

Medicine (Health Sciences)